A comprehensive view of U.S. House of Representatives. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.
US Rep. James Comer expresses concerns about the FDA's prioritization of safety, effectiveness, and innovation during House Oversight Committee hearing
Published:
April 12, 2024
by Targeted News Service (Press Releases)
|
GPO director requests FY2025 appropriations in amount of US$136.1M from Congress, a 3.1% increase over GPO's FY2024 appropriation; direct appropriations represent only about 10% of GPO's total projected revenue for FY 2025 of US$1.3B
Published:
April 10, 2024
by U.S. Government Publishing Office
|
US House passes outdoor recreation bill, the EXPLORE Act, without cost to taxpayers; the act aims to enhance access to outdoor adventures and green spaces, especially for underserved communities, and bolster the US$1.1T outdoor recreation economy
Published:
April 09, 2024
by RV Industry Association
|
Bill introduced in US House to strip COVID-19 vaccine makers of liability protection; the retroactive legislation ensures access to existing compensation schemes for those injured by the vaccine
Published:
March 06, 2024
by The Washington Times
|
US Representative Brad Wenstrup probes approval of Pfizer's COVID-19 vaccine by the FDA, hinting at possible political pressure from the Biden administration despite warnings by scientists about rushing the process
Published:
March 05, 2024
by Congressional Documents & Publications
|
Ask us about our Consumer Wellness market view